We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 14.89%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$817M
AUM Growth
-$36.2M
Cap. Flow
-$39.4M
Cap. Flow %
-4.82%
Top 10 Hldgs %
12.04%
Holding
1,060
New
418
Increased
118
Reduced
111
Closed
413

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$12.8M
2
CRM icon
Salesforce
CRM
+$9.18M
3
NKE icon
Nike
NKE
+$8.85M
4
DHR icon
Danaher
DHR
+$8.43M
5
AMZN icon
Amazon
AMZN
+$8.08M

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$17.9M
2
TSLA icon
Tesla
TSLA
+$16.6M
3
CVX icon
Chevron
CVX
+$15.3M
4
MDB icon
MongoDB
MDB
+$9.4M
5
FTNT icon
Fortinet
FTNT
+$8.82M

Sector Composition

Rank Sector Weight
1 Technology 22.57%
2 Consumer Discretionary 15.97%
3 Healthcare 14.57%
4 Industrials 11.33%
5 Financials 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NOG icon
451
Northern Oil and Gas
NOG
$2.73B
$357K 0.04%
+9,600
New +$376K
ST icon
452
Sensata Technologies
ST
$6.07B
$356K 0.04%
+13,000
New +$422K
AVTR icon
453
Avantor
AVTR
$9.83B
$356K 0.04%
+16,900
New +$380K
PJT icon
454
PJT Partners
PJT
$4.6B
$356K 0.04%
+2,254
New +$344K
NSC icon
455
Norfolk Southern
NSC
$78B
$352K 0.04%
+1,500
New +$381K
HI
456
DELISTED
Hillenbrand
HI
$350K 0.04%
+11,364
New +$343K
RARE icon
457
Ultragenyx Pharmaceutical
RARE
$2.55B
$348K 0.04%
8,268
-5,568
-40% -$276K
CALY
458
Callaway Golf Company
CALY
$2.83B
$347K 0.04%
44,200
-6,700
-13% -$60.8K
UNFI icon
459
United Natural Foods
UNFI
$2.84B
$347K 0.04%
+12,700
New +$293K
HWC icon
460
Hancock Whitney
HWC
$6.04B
$345K 0.04%
+6,307
New +$349K
RDFN
461
DELISTED
Redfin
RDFN
$344K 0.04%
43,700
-58,800
-57% -$570K
PBF icon
462
PBF Energy
PBF
$8.2B
$332K 0.04%
+12,500
New +$380K
CSIQ icon
463
Canadian Solar
CSIQ
$904M
$331K 0.04%
+29,800
New +$384K
BZ icon
464
Kanzhun
BZ
$8B
$331K 0.04%
+24,000
New +$353K
ONC
465
BeOne Medicines Ltd
ONC
$41.6B
$331K 0.04%
+1,791
New +$366K
GFI icon
466
Gold Fields
GFI
$41.5B
$330K 0.04%
+25,000
New +$381K
FIVE icon
467
Five Below
FIVE
$13.5B
$327K 0.04%
+3,115
New +$298K
OLO
468
DELISTED
Olo Inc
OLO
$327K 0.04%
42,526
+29,700
+232% +$186K
OZK icon
469
Bank OZK
OZK
$5.41B
$324K 0.04%
7,283
+1,627
+29% +$74.4K
AG icon
470
First Majestic Silver
AG
$10.4B
$322K 0.04%
+58,600
New +$378K
GFF icon
471
Griffon
GFF
$4.48B
$322K 0.04%
+4,513
New +$327K
OSPN icon
472
OneSpan
OSPN
$601M
$321K 0.04%
17,311
+300
+2% +$5.1K
CHDN icon
473
Churchill Downs
CHDN
$6.11B
$320K 0.04%
+2,400
New +$332K
RDNT icon
474
RadNet
RDNT
$5.85B
$319K 0.04%
+4,563
New +$337K
KTB icon
475
Kontoor Brands
KTB
$4.24B
$318K 0.04%
+3,729
New +$320K
17 18
19
20 21

Similar funds

MCM
Mork Capital Management Healdsburg, California $156M AUM 39.85% 1-Year Est. Return
MFG
Mosaic Financial Group Chicago, Illinois $156M AUM 23.77% 1-Year Est. Return
AFW
Atlantic Family Wealth Coral Gables, Florida $156M AUM 21.68% 1-Year Est. Return
ADBIC
A.D. Beadell Investment Counsel Mequon, Wisconsin $156M AUM 29.03% 1-Year Est. Return
HSM
H Squared Management New York $156M AUM
FWM
FMA Wealth Management Duxbury, Massachusetts $156M AUM 15.22% 1-Year Est. Return
PIA
Polaris Investment Advisors Framingham, Massachusetts $156M AUM
CCP
Cyrus Capital Partners New York $156M AUM 81.61% 1-Year Est. Return

Bayesian Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Bayesian Capital Management held 1,060 positions worth $817M, down 4.2% from $853M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Bayesian Capital Management withdrew a net $39.4M in Q4 2024, closing 413 positions and reducing 111 holdings. Its most notable exit was Netflix, an estimated $17.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bayesian Capital Management opened a new position in Amgen worth $11.2M.

  • Bayesian Capital Management's largest Q4 2024 buy was Amgen: 43,000 shares worth $11.2M.
  • Bayesian Capital Management added most to Nike in Q4 2024, an estimated $8.85M increase.
  • Bayesian Capital Management's biggest Q4 2024 reduction was Tesla, cutting an estimated $16.6M.
  • Bayesian Capital Management fully exited Netflix in Q4 2024, selling an estimated $17.9M.
  • Bayesian Capital Management's ten largest holdings make up 12% of its $817M portfolio in Q4 2024.
  • Bayesian Capital Management opened 418 new positions and closed 413 in Q4 2024.
  • Bayesian Capital Management's portfolio value fell 4.2% quarter-over-quarter to $817M.

Based on Bayesian Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.